Cargando…
Stable and exacerbation period serum cytokine and periostin levels of the five distinct phenotypes of severe asthma
BACKGROUND/AIM: The differences in molecular mechanisms during a stable period and the changes in the inflammatory responses during exacerbations between distinct severe asthma phenotypes remain unclear. In this study, we aimed to characterize stable and exacerbation period serum cytokine and perios...
Autores principales: | TÜRK, Murat, YILMAZ, İnsu, GÖKAHMETOĞLU, Selma, KOÇ, Ayşe Nedret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific and Technological Research Council of Turkey (TUBITAK)
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388125/ https://www.ncbi.nlm.nih.gov/pubmed/36326393 http://dx.doi.org/10.55730/1300-0144.5418 |
Ejemplares similares
-
Effectiveness of mepolizumab therapy on symptoms, asthma exacerbations, steroid dependence, and small airways in patients with severe eosinophilic asthma
por: YILMAZ, İnsu, et al.
Publicado: (2021) -
Molecular T2 asthma phenotypes are stable but heterogeneous: the usefulness of periostin for endotyping
por: Bobolea, Irina, et al.
Publicado: (2023) -
Serum Periostin Level in Children with Asthma
por: Kumar, Ketan, et al.
Publicado: (2022) -
Efficacy of mepolizumab treatment in oral corticosteroid-dependent severe eosinophilic asthma patients with chronic rhinosinusitis with nasal polyps: single center, real life study
por: YILMAZ, İnsu, et al.
Publicado: (2020) -
Using Periostin as a Biomarker in the Treatment of Asthma
por: Izuhara, Kenji, et al.
Publicado: (2016)